Emergent Gets Investor Suit Over COVID Vaccine Trimmed
A Maryland federal judge trimmed a consolidated class action claiming that Emergent BioSolutions Inc. misled investors about how prepared it was to handle two high-profile deals to manufacture COVID-19 vaccines, ruling...To view the full article, register now.
Already a subscriber? Click here to view full article